Alaunos Therapeutics SG&A Expense (TTM) Analysis

Alaunos Therapeutics Inc (TCRT)

3.11 -0.43 (-12.15%) USD | NASDAQ | Sep 27, 16:00

3.00 -0.11 (-3.54%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2001. Upgrade now.

Date	Value
June 30, 2024	8.613M
March 31, 2024	10.67M
December 31, 2023	12.22M
September 30, 2023	12.72M
June 30, 2023	12.42M
March 31, 2023	12.80M
December 31, 2022	13.14M
September 30, 2022	12.31M
June 30, 2022	17.20M
March 31, 2022	22.84M
December 31, 2021	27.56M
September 30, 2021	34.27M
June 30, 2021	32.45M
March 31, 2021	29.94M
December 31, 2020	27.66M
September 30, 2020	24.68M
June 30, 2020	23.14M
March 31, 2020	21.34M
December 31, 2019	19.53M
September 30, 2019	18.27M
June 30, 2019	17.77M
March 31, 2019	17.90M
December 31, 2018	19.92M
September 30, 2018	19.21M
June 30, 2018	18.47M

Date	Value
March 31, 2018	17.36M
December 31, 2017	14.80M
September 30, 2017	14.26M
June 30, 2017	14.23M
March 31, 2017	14.16M
December 31, 2016	14.38M
September 30, 2016	14.32M
June 30, 2016	13.84M
March 31, 2016	17.21M
December 31, 2015	17.65M
September 30, 2015	17.24M
June 30, 2015	17.02M
March 31, 2015	12.97M
December 31, 2014	12.17M
September 30, 2014	13.52M
June 30, 2014	13.74M
March 31, 2014	14.43M
December 31, 2013	15.66M
September 30, 2013	15.52M
June 30, 2013	18.16M
March 31, 2013	19.35M
December 31, 2012	19.52M
September 30, 2012	19.43M
June 30, 2012	17.46M
March 31, 2012	16.48M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

8.613M

Minimum

Jun 2024

34.27M

Maximum

Sep 2021

19.69M

Average

18.90M

Median

SG&A Expense (TTM) Benchmarks